Indaptus Therapeutics, Inc. (INDP) Misses Q1 EPS by 14c

Indaptus Therapeutics, Inc. (NASDAQ: INDP) reported Q1 EPS of ($0.32), $0.14 worse than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Indaptus Therapeutics, Inc. (INDP) click here.

You May Also Be Interested In

• Hawaiian Electric trades at 8.8x P/E, but wildfire risk clouds value case
• Dell Technologies (DELL) call put ratio 1.1 calls to 1 put into quarter results
• Increasing unusual option volume: GPRO ALMS DPRO FRVO DUST HWM NVS CRK EIX